[Diffuse panbronchiolitis (DPB)].
Azuma
Arata
A
Fourth Department of Internal Medicine, Nippon Medical School.
Kudoh
Shoji
S
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents; D001988:Bronchiolitis / Q000188:drug therapy / Q000453:epidemiology; D002896:Chromosomes, Human, Pair 6 / Q000235:genetics; D065607:Cytochrome P-450 Enzyme Inhibitors; D003864:Depression, Chemical; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D015395:Histocompatibility Antigens Class I / Q000235:genetics; D006801:Humans; D007564:Japan / Q000453:epidemiology; D018942:Macrolides; D009092:Mucous Membrane / Q000378:metabolism; D012137:Respiratory System / Q000378:metabolism; D015996:Survival Rate; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D065607:Cytochrome P-450 Enzyme Inhibitors; D015395:Histocompatibility Antigens Class I; D018942:Macrolides